Prevalence of distressing symptoms in hospitalised patients on medical wards: A cross-sectional study by Sigurdardottir, Katrin Ruth & Haugen, Dagny Faksvåg
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Palliative Care
Open Access Research article
Prevalence of distressing symptoms in hospitalised patients on 
medical wards: A cross-sectional study
Katrin Ruth Sigurdardottir*1,2,3 and Dagny Faksvåg Haugen2,4
Address: 1Sunniva Clinic for Palliative Medicine, Haraldsplass Deaconal Hospital, N-5008 Bergen, Norway, 2Regional Centre of Excellence for 
Palliative Care, Western Norway, Haukeland University Hospital, N-5021 Bergen, Norway, 3Department of Internal Medicine, Haukeland 
University Hospital, N-5021 Bergen, Norway and 4Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian 
University of Science and Technology, N-7006 Trondheim, Norway
Email: Katrin Ruth Sigurdardottir* - katrin.sigurdardottir@haraldsplass.no; Dagny Faksvåg Haugen - dagny.haugen@ntnu.no
* Corresponding author    
Abstract
Background:  Many patients with advanced, serious, non-malignant disease belong to the
population generally seen on medical wards. However, little research has been carried out on
palliative care needs in this group. The aims of this study were to estimate the prevalence of
distressing symptoms in patients hospitalised in a Department of Internal Medicine, estimate how
many of these patients might be regarded as palliative, and describe their main symptoms.
Methods: Cross-sectional (point prevalence) study. All patients hospitalised in the Departments
of Internal Medicine, Pulmonary Medicine, and Cardiology were asked to do a symptom assessment
by use of the Edmonton Symptom Assessment System (ESAS). Patients were defined as "palliative"
if they had an advanced, serious, chronic disease with limited life expectancy and symptom relief as
the main goal of treatment.
Results: 222 patients were registered in all. ESAS was completed for 160 patients. 79 (35.6%) were
defined as palliative and 43 of them completed ESAS. The patients in the palliative group were older
than the rest, and reported more dyspnea (70%) and a greater lack of wellbeing (70%). Other
symptoms reported by this group were dry mouth (58%), fatigue (56%), depression (41%), anxiety
(37%), pain at rest (30%), and pain on movement (42%).
Conclusion: More than one third of the patients in a Department of Internal Medicine were
defined as palliative, and the majority of the patients in this palliative group reported severe
symptoms. There is a need for skills in symptom control on medical wards.
Background
Populations in developed countries are ageing, and an
increasing number of persons live with the effects of seri-
ous chronic illnesses towards the end of life. Most deaths
in European and other developed countries occur in peo-
ple more than 65 years old [1]. In 2005, there were 41,152
deaths registered in Norway, 83.5% occurred in people
aged above 65, and cardiovascular disease (34.4%) and
cancer were the causes of more than 60% of all deaths [2].
The top five predicted causes of death for 2020 are heart
disease, cerebrovascular disease, chronic respiratory dis-
ease, respiratory infections, and lung cancer [3]. Most of
the patients with advanced, serious, non-malignant dis-
ease belong to the population generally seen on medical
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wards. None the less, comparatively little research has
been carried out on their needs for palliative care. To our
knowledge, no survey on the prevalence of distressing
symptoms in an internal medicine population has been
performed in Norway, and the literature on this topic is
generally scarce. The present study was planned to get an
impression of the palliative care needs of a general medi-
cal inpatient population. In addition, the results would be
useful when planning a palliative care service for our
regional university hospital.
Methods
This was a cross-sectional (point prevalence) study per-
formed at Haukeland University Hospital on 17th Febru-
ary 2005. Haukeland University Hospital is a regional
teaching hospital with 1100 beds and about 200 admis-
sions daily.
All patients hospitalised in the Departments of Internal
Medicine, Pulmonary Medicine, and Cardiology (216
beds in all) were asked to do a symptom assessment by
use of a slightly modified ESAS (Edmonton Symptom
Assessment System) questionnaire [4], filled in by the
patients themselves or by interview. All patients received
written and oral information about the study and gave
informed consent.
The ESAS questionnaire evaluates nine common symp-
toms in palliative care patients as well as general wellbe-
ing [4-6]. Numerical rating scales (NRS) from 0 to 10 are
used to describe symptom severity, 0 indicating no symp-
tom and 10 indicating worst possible distress. The system
has been widely used in palliative care settings [7]. In the
present study, scores < 3 on the scales were defined as nor-
mal or no symptom present. Scores ≥ 3 were defined as
symptom present, and scores ≥ 5 as symptom present and
severe. These cut points have been used in similar studies
[8-11] and are also in accordance with official Norwegian
recommendations [4].
Ward staff recorded the following background informa-
tion on the forms: age group, gender, main diagnoses
(maximum three), and number of days in hospital.
Patients were excluded from the study if they were cogni-
tively impaired or otherwise unfit to participate, if they
had had surgery the preceding day, or if they were unwill-
ing to participate.
Patients were defined as "palliative" if they had an
advanced, serious, chronic disease with limited life
expectancy and symptom relief as the main goal of treat-
ment. This categorization was denoted by attending staff
on the wards, nurses and/or physicians. In case of doubt,
the staff was told to ask themselves the following ques-
tion, "Would you be surprised if this patient died in the
course of the next nine months?" If the answer was no, the
patient could be defined as palliative.
The study was approved by the Regional Committee for
Medical Research Ethics and the Privacy Issues Unit of the
Norwegian Social Science Data Services.
Results
All patients
Altogether 232 patients were recorded as inpatients on the
wards in question on the day of the study. A total of 222
patients were registered in the study (Fig. 1). Ten patients
were not asked to participate due to circumstances on
their ward and lack of time for the staff.
Sixty-two patients were excluded from the study due to the
following reasons: 32 patients were not able to partici-
pate, 19 patients were not willing to participate, six
patients had undergone surgery in the last 24 hours, four
patients were not able to complete the questionnaire or
the interview (drop outs), and one patient was in a state
in which it was deemed unethical to ask for participation.
ESAS was completed for 160 patients. In 105 cases (66%)
the ESAS was completed by the patients themselves. In the
remaining 55 cases (34%) the questionnaire was filled in
by the staff by interview.
More than 50% of the included patients reported fatigue
(61%), dry mouth (53%), and lack of wellbeing (56%),
and 49% reported dyspnea and lack of appetite (NRS ≥ 3).
Within the group reporting symptoms, more than half of
the patients rated their symptoms as severe (NRS ≥ 5).
Pain at rest was reported by 34% of all included patients,
and pain on movement by 43%. Eighteen % of the
patients reported nausea.
With respect to diagnosis, the study population was very
heterogeneous, with 54% having more than one main
diagnosis. The diagnostic group heart and vascular dis-
eases (N = 52) covered a variety of diagnoses with differ-
ent symptom profiles. Chronic obstructive lung disease
(COPD) patients (N = 27) were a much more uniform
group, presenting high scores for dyspnea and lack of
wellbeing. In the COPD group, 81% of the patients rated
their dyspnea as severe (NRS ≥ 5), and 46% reported a
severe lack of well-being, compared to 25% in the group
not having this diagnosis.
Among the 160 included patients, 117 were denoted as
non-palliative. Their characteristics are shown in Table 1,
and the symptom distribution in this group is presented
in Fig. 2. Fatigue was the most prevalent symptom. There
were 13 cancer patients in the non-palliative group. TheBMC Palliative Care 2008, 7:16 http://www.biomedcentral.com/1472-684X/7/16
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cancer patients had more pain and nausea than the
patients with other diagnoses, while dyspnea was more
common in the non-cancer patients.
The palliative patient subgroup
Seventy-nine patients (35.6%) were defined as palliative
by the attending staff on the wards (Fig. 1). Their diag-
noses were denoted by the attending staff and are pre-
sented in Table 1.
Forty-three of the palliative patients were included in the
study, and 36 were excluded.
Altogether, there were more male than female patients in
the palliative group, and almost twice as many males from
the palliative group were included in the study. The
included and excluded palliative patients had very similar
mean and median lengths of stay.
The patients in the palliative group were older than the
ones not denoted as palliative, with 80% of the palliative
patients above 70 years of age, and 40% above 80.
The palliative patients that were excluded from the study
mainly belonged to the highest age group (>80 years).
Participant distribution in the study Figure 1
Participant distribution in the study.
232 patients hospitalised in the 
Departments of Internal Medicine, 
Pulmonary Medicine, and Cardiology
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The average total ESAS score (symptom distress score) for
the included palliative patients was 29.5 (range 6–83).
The symptom distribution within the palliative group is
shown in Fig. 2. Seventy percent of the palliative patients
reported dyspnea and lack of wellbeing. Other symptoms
reported by this group were dry mouth (58%), fatigue
(56%), depression (41%), anxiety (37%), pain at rest
(30%), and pain on movement (42%). Fig. 2 shows that
the majority of palliative patients reporting symptoms
rated their symptoms as severe. Almost 45% of the
included palliative patients reported severe dyspnea, and
40% a severe lack of wellbeing. Twenty-three % of the pal-
liative patients reported severe pain at rest and one third
of the group severe pain on movement. Thirty percent of
the included patients in the palliative group felt severely
depressed. The palliative patients reported more severe
dyspnea, more depression, and a greater lack of wellbeing
than the non-palliative patients did (Fig. 2). Within the
palliative subgroup, the 16 cancer patients reported a
greater lack of wellbeing than non-cancer patients, while
patients with non-cancer diagnoses reported more severe
dyspnea.
Discussion
This cross-sectional study shows that more than one third
of the patients in a Department of Internal Medicine were
defined as palliative, and that the majority of the patients
in this palliative group reported distressing symptoms.
In many cases it proved difficult for the staff to decide
whether the patient should be regarded as "palliative" or
not. Generally, the nurses and doctors were restrictive in
their use of the term "palliative". Several patients were
added to the palliative group when we asked our question
"Would you be surprised if this patient died in the course
of the next nine months?" When looking through the
completed forms afterwards, we noted several patients
whom we clearly would have defined as palliative, but
who were not marked as such. However, in order not to
introduce any bias, we did not alter anything. We there-
fore think that the number of palliative patients reported
here is underestimated.
A large proportion of patients in the palliative group were
excluded from the study due to cognitive impairment or
because their general condition made them unfit to partic-
Table 1: Characteristics of the study population, comparing the palliative and the non-palliative group.
Palliative group Non-palliative group
Included 
N = 43 (19)#
Excluded 
N = 36 (16)
Included 
N = 117 (53)
Excluded 
N = 26 (12)
All patients 
N = 222*
Gender
Female 16 (37.2) 16 (44.4) 61 (52.1) 11 (42.3) 104 (46.8)
Male 27 (62.7) 20 (55.6) 56 (47.9) 15 (57.7) 118 (53.1)
Age groups
Age < 31 - - 13 (11.1) 3 (11.5) 16 (7.2)
Age 31–40 1 (2.3) - 12 (10.3) 4 (15.4) 17 (7.7)
Age 41–50 2 (4.7) - 17 (14.5) 2 (7.7) 21 (9.5)
Age 51–60 1 (2.3) - 23 (19.7) 4 (15.4) 28 (12.6)
Age 61–70 9 (20.9) 2 (5.6) 20 (17.1) 6 (23.1) 37 (16.7)
Age 71–80 19 (44.2) 10 (27.8) 23 (19.7) 4 (17.4) 56 (25.2)
Age 81–90 9 (20.9) 18 (50.0) 7 (6.0) 3 (11.5) 37 (16.7)
Age > 91 2 (4.7) 6 (16.7) 2 (1.7) - 10 (4.5)
Number of diagnoses
One diagnosis 12 (27.9) 11 (30.6) 62 (53.0) 15 (57.7) 100 (45.0)
Two diagnoses 15 (34.9) 12 (33.3) 36 (30.8) 7 (27.0) 70 (31.5)
Three diagnoses 16 (37.2) 13 (36.1) 19 (16.2) 4 (15.4) 52 (23.4)
Diagnosis
Renal failure 3 (6.9) 1 (2.8) 6 (5.2) 3 (11.5) 13 (5.9)
COPD 14 (32.6) 5 (13.9) 13 (11.1) 1 (3.8) 33 (14.9)
Heart and vascular diseases 21 (48.9) 15 (41.7) 31 (26.5) 6 (23.1) 73 (32.9)
Cancer 16 (37.2) 3 (8.3) 13 (11.1) 2 (7.7) 34 (15.3)
Mean days in hospital 10.6 11.5 8.8 11.8 9.9
# Percentages are given in brackets. Percentages given in the column headings and the column to the far right relate to the total number of patients 
(222), while percentages given for each of the four subgroups relate to the number of patients within that group.
*232 patients were recorded as inpatients on the day of the study. Ten patients were not asked to participate due to circumstances on their ward.BMC Palliative Care 2008, 7:16 http://www.biomedcentral.com/1472-684X/7/16
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Comparison of symptoms between the palliative patient subgroup (N = 43) and the non-palliative group (N = 117) Figure 2
Comparison of symptoms between the palliative patient subgroup (N = 43) and the non-palliative group (N = 
117). The red and black columns show the palliative patient subgroup; the red columns show the proportion of palliative 
patients with NRS score 3–4 for each symptom, and the black columns show the proportion of palliative patients with NRS 
score ≥ 5 for each symptom. The white columns show the proportion of non-palliative patients with NRS 3–4 for each symp-
tom, and the grey columns show the proportion of non-palliative patients with NRS ≥ 5 for each symptom.
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ipate. This led to a reduced inclusion rate in the palliative
subgroup. However, the high age and poor general condi-
tion of these patients add additional evidence that this
group constituted a palliative care population.
In a recent review of symptom prevalence in advanced,
life-threatening disease, the three symptoms pain, breath-
lessness, and fatigue were described among more than
50% of patients with advanced cancer, AIDS, heart dis-
ease, COPD, and renal disease [12]. This is consistent with
our findings for dyspnea (70%) and fatigue (56%), which
were the dominating symptoms in the present study.
Solano and coworkers reported a pain prevalence of
between 34% and 77% in heart disease and COPD in dif-
ferent studies [12]. Pain on movement was reported by
43% in our palliative group. The prevalence of depression
in our study is also consistent with other reports [12].
According to Norwegian recommendations we used the
value 3 on the numerical rating scales as cut-off point for
symptom presence [4]. This is more restrictive than in sev-
eral other studies and may influence the prevalence num-
bers [6,9,11].
This study demonstrates that patients in a Department of
Internal Medicine have a high prevalence of distressing
symptoms and that there consequently is a need for skills
in symptom control on the ward. A thorough assessment
is a prerequisite for successful symptom relief. We used a
modified ESAS questionnaire in our study [4,5]. The ESAS
is an example of a quick and clinically relevant symptom
assessment tool. Although developed for palliative care
cancer patients, the tool covers a range of symptoms
which also commonly is present in advanced non-malig-
nant disease [12]. Routine use of ESAS is a help to reveal
new symptoms, prioritize between symptoms, and repeat-
edly evaluate the degree of symptom control obtained.
However, symptom assessment is particularly challenging
in some subgroups. These include cognitively impaired
patients, patients whose language or culture differs from
that of the health care professionals, and the imminently
dying. The present study confirms that many patients in a
palliative care population are too weak to use self-rating
assessment tools, and that other approaches must be used.
Family members and staff may be useful proxies for clini-
cal and research purposes, but their data must be inter-
preted cautiously [11,13,14]. Numerous studies have
demonstrated that observer and patient assessments are
not highly correlated [11,13-15]. For non-verbal patients
with severe cognitive impairment, pain assessment must
rely on behavioural scales [16]. Although some observa-
tional tools exist, additional research is needed regarding
instruments for symptom assessment in patients who can-
not give subjective ratings.
Although the situation varies between the countries, the
majority of palliative care services in Europe have cancer
patients as their main target population [17]. In Norway,
more than 90% of the patients in specialist palliative care
are cancer patients [4]. However, our study reveals consid-
erable palliative care needs in an inpatient population of
a general medical department, representing an unselected,
heterogeneous patient population. These findings clearly
have implications for the planning and development of
the palliative care services in our hospital. First of all, the
attending staff on the wards must possess skills in pallia-
tive care to make a valid symptom assessment and provide
basic symptom relief. In addition, there is a need for spe-
cialist palliative care providers with experience in non-
cancer care to work in close cooperation with the ward
staff. We also think that the present findings are represent-
ative of Internal Medicine Departments in many hospi-
tals, both in Norway and abroad, and may even apply to
Surgical services and Neurology Departments. In many
hospitals, all of these departments mainly care for patients
in the older age group, with advanced disease and signifi-
cant comorbidities.
The present study only focused on symptom prevalence as
measured by the ESAS, which is an obvious limitation
with respect to needs assessment. Understanding needs
outside of symptoms, like spiritual challenges, family and
carer needs, and coordination of services, forms a natural
part of palliative care and should be included in a com-
plete survey. However, even if the evidence is limited, pre-
vious studies have shown that e.g. family anxiety and lack
of psychological support are prevalent also in non-cancer
[18]. Given the symptom burden, we do not anticipate
that spiritual, social, or psychological needs are very dif-
ferent in a non-cancer population compared to a cancer
population in the last year of life.
Comprehensive palliative care successfully improves the
quality of life for cancer patients and families, and has
also been shown to reduce the overall cost of care by
reducing the amount of time spent in acute hospital set-
tings [19]. This option must be expanded to patients with
other advanced, progressive, life-threatening diseases.
Providing palliative care for advanced, chronic non-
malignant disease may be more challenging than for can-
cer patients due to difficulties related to establishing a
prognosis or identifying the patients' needs [18,20]. How-
ever, these challenges should not prevent suffering
patients from getting optimal symptom relief. Palliative
care should not only be offered by specialist teams or
units when all other treatments have failed, but be an inte-
gral part of good patient care in any setting.Publish with BioMed Central    and   every 
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Conclusion
More than one third of the patients in a Department of
Internal Medicine were defined as palliative, and the
majority of the patients in this palliative group reported
severe symptoms. There is a need for skills in symptom
control on medical wards. Services should be available on
the basis of need in terms of symptoms and problems
rather than on the basis of diagnosis.
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